In Alzheimer’s disease (AD), RORγ- or IL-17-expressing Th17 Teffs were significantly increased in AD patients with mild cognitive impairment (MCI) compared to control populations (Saresella et al., 2011; Oberstein et al., 2018). The gene discussed is IL17A; the disease is Alzheimer disease.